Microtubule-associated protein 1 light chain 3 has an important role in autophagy. The human LC3 gene family has five members, LC3A (variant-1: v1 and -2: v2), LC3B, LC3B2 and LC3C. Although a form of LC3B modified by phosphatidylethanolamine (form-II) is localized in autophagosomes, it is not clear whether other LC3 proteins also function in autophagy. Here, we examined the association between autophagy and human LC3 proteins during starvation-or p53-induced autophagy in Saos-2 cells. In an analysis of the intracellular distribution of each LC3 protein fused with GFP, GFP-LC3Av1 was frequently localized in autophagosomes with a punctate pattern, similar to GFP-LC3B. Further, endogenous LC3Av1 generated form-II and mostly localized in LC3B-positive autophagosomes during the induced autophagy. Interestingly, LC3Av1, not LC3B, was frequently inactivated at the transcriptional level in various human cancer cell lines (111/244 cell lines, 45.5%) and its inactivation was due to aberrant DNA methylation in esophageal squamous cell carcinoma (ESCC) cell lines and primary tumors. Restoration of LC3Av1 expression in KYSE170 cells, an LC3Av1-inactivated ESCC cell line, showed the inhibition of tumor growth in vivo. These results suggest that LC3Av1, not only LC3B, functions in autophagy and further, LC3Av1 may be crucial in carcinogenesis.
Introduction
Macroautophagy (hereafter referred to as autophagy) is an intracellular trafficking pathway for bulk degradation of portions of the cytosol and intracellular organelles in lysosomes (Rubinsztein, 2006; Mizushima, 2007; Cecconi and Levine, 2008; Mizushima et al., 2008; Virgin and Levine, 2009 ). This process functions as a flux, with portions of the cytosol and intracellular organelles sequestered into autophagosomes, which fuse with intracellular vesicles and eventually develop into autolysosomes by fusing with lysosomes, responsible for supplying acid hydrolases. Autophagy is an evolutionally conserved pathway from yeast to mammals. It is important for a number of physiological processes, including adaptation to starvation, prevention of neurodegeneration, presentation of intracellular antigens and tumor suppression (Cecconi and Levine, 2008; Mizushima et al., 2008; Virgin and Levine, 2009 ). Additionally, accumulating evidence indicates that p53, a tumor suppressor protein, can modulate autophagy machinery in a dual fashion, depending on its subcellular localization; the nuclear p53 can induce autophagy through transcriptional activation of autophagy-related genes including DRAM, whereas the cytoplasmic p53 can inhibit autophagy via poorly characterized mechanisms (Crighton et al., 2006; Tasdemir et al., 2008; Maiuri et al., 2010) .
Microtubule-associated protein 1 light chain 3 (indicate LC3b) was originally identified as a protein co-purified with microtubule-associated proteins (MAP1A and MAP1B) from rat brain (Kuznetsov and Gelfand, 1987; Mann and Hammarback, 1994) . Rat LC3 (rLC3) shows 28% amino-acid identity with yeast Atg8, a factor crucial for autophagy in yeast, and a form modified by phosphatidylethanolamine (PE) (so-called form-II) localized in the autophagosome membrane (Kabeya et al., 2000 (Kabeya et al., , 2004 . Moreover, it has been known that two other mammalian homologs of yeast Atg8, g-aminobutyricacid-type-A-receptor-associated protein and Golgi-associated ATPase enhancer of 16 kDa, were also localized in the autophagosome membrane and generated form-II (Kabeya et al., 2004) . Thus, the increase in form-II of Atg8 homologs and the punctate intracellular distribution of Atg8 homologs fused with green fluorescence protein (GFP) (especially GFP-rLC3) are useful indicators of autophagosomes in mammalian cells (Kabeya et al., 2000 (Kabeya et al., , 2004 .
In humans, three LC3 genes (LC3A, LC3B and LC3C) have been identified as homologs of yeast Atg8, whereas two Lc3 genes, Lc3a and Lc3b, have been characterized in rat (He et al., 2003; Wu et al., 2006) . NCBI database revealed that two variants (v1 and v2) of LC3A with different transcriptional start sites and LC3B2 at a different locus from LC3B. Although LC3B is used as an indicator of autophagosomes, it is not clear whether the other four LC3 proteins also localize to autophagosomes during the induced autophagy.
In this study, we examined the association between autophagy and individual human LC3 proteins during starvation-or p53-induced autophagy in Saos-2 cells. We found that LC3Av1 as well as LC3B functions in the autophagy as indicated by an increase in form-II and its co-localization with LC3B-positive autophagosomes. Interestingly, LC3Av1, not LC3B, was epigenetically inactivated by aberrant DNA methylation in various human cancer cell lines and primary esophageal squamous cell carcinoma (ESCC). In addition, the inhibition of tumor growth in vivo was confirmed by restoration of LC3Av1 expression in KYSE170 cells, an LC3Av1-inactivated ESCC cell line. Our findings suggest LC3Av1, not only LC3B, is associated with autophagy and its inactivation may also contribute to carcinogenesis.
Results
The human microtubule-associated protein 1 light chain 3 gene family In humans, three LC3 genes (LC3A, LC3B and LC3C) have been identified as homologs of yeast Atg8 (He et al., 2003) . However, a search of the NCBI database uncovered two transcriptional variants (v1 and v2) of LC3A with different transcriptional start sites, and LC3B2 located at a different locus from LC3B (LC3B: 16q24, and LC3B2: 12q24) (Figure 1a ). LC3Av1 and LC3Av2 differ in N-terminal sequence (Figure 1b) . Among LC3B and LC3B2, one different nucleotide results in a different amino acid (Tyr: Y for LC3B and Cys: C for LC3B2 in the 113 amino acid) (Figure 1c) . Further, we compared amino acid sequences for LC3 proteins among vertebrates and found that: (1) LC3a and LC3b were mostly the same among species, (2) LC3a (human LC3Av1) and LC3b (human LC3B) differed slightly in each species (in about 15% of amino acids) and (3) homologs of human LC3Av2, LC3B2 and LC3C have yet to be identified in other species (Figure 1d ). In addition, the analysis of five human LC3 genes in various normal tissues revealed that LC3Av1 and LC3B are ubiquitously expressed in almost all tissues as reported (He et al., 2003) , whereas the expression of LC3Av2, LC3B2 and LC3C is extremely low and/or tissue-specific (Figure 1e ).
Distribution of human LC3 proteins during the induced autophagy in Saos-2 cells LC3B is often used as an indicator of autophagosomes, but it is not clear whether the other four LC3 proteins also localized in autophagosomes during the induced autophagy. We examined the intracellular distribution of each human LC3 protein fused with GFP in Saos-2 cells, in which autophagy was induced by starvation or p53 activation (Crighton et al., 2006) . As indicated in Figure 2a , when Saos-2 cells stably expressing each GFP-LC3 protein were starved or infected with adenoviral p53 (Ad-p53), GFP-LC3Av1 frequently exhibited a punctate distribution similar to GFP-rLC3b and -LC3B as the positive control. The number of GFPLC3Av1-positive puncta was remarkably increased, as well as that of GFP-rLC3b and -LC3B-positive puncta, whereas the number of GFP-LC3Av2 and -LC3B2-positive puncta was only slightly increased ( Figure 2b) . Furthermore, when the starvation-or p53 activationinduced autophagy flux was inhibited by treatment with Bafilomycin A1 (Baf.A1), a lysosomal inhibitor, we showed that puncta of GFP-LC3Av1, as well as GFPrLC3 and -LC3B, were more accumulated than those of GFP-LC3Av2 and -LC3B2, suggesting that GFPLC3Av1 unambiguously localized into the formed autophagosomes ( Figure 2a ). On the other hand, GFP-LC3C was shown as smaller punctate pattern comparing with GFP-LC3Av1, -LC3B and -rLC3b even under normal conditions, and the number of small puncta was constantly >15 dots in one cell and was not increased after induction of the autophagy (Figures 2a  and b) . Additionally, GFP-LC3C-positive small puncta remained to appear even when the autophagy was pharmacologically inhibited by treatment with wortmannin or 3-MA (data not shown).
Next, using western blotting we examined the status of modification by PE of the GFP-LC3 proteins during the induced autophagy in Saos-2 cells. When autophagosomes were formed as a result of starvation or infection with Ad-p53, no increase in form-II of the GFP-LC3 proteins was found. Treatment with Baf.A1 under the conditions that induced autophagy resulted in an increase in form-II in GFP-LC3Av1 as well as GFPrLC3b and -LC3B, but not in GFP-LC3Av2 and -LC3B2 (Supplementary Figure S1 ). This observation indicates the turnover of autophagosomes in lysosomes to be very fast in Saos-2 cells. Importantly, form-II of endogenous LC3B was also equally increased in each clone (Supplementary Figure S1 ), indicating no remarkable difference in the efficiency of autophagy among the clones. Taken together, these findings suggest that LC3Av1, not only LC3B, localized more frequently in autophagosomes than did LC3Av2 and LC3B2, and that LC3C may not be localized to autophagosomes.
Distribution and modification of endogenous LC3Av1 during the induced autophagy We examined whether endogenous LC3Av1 is modified by PE and localizes in the autophagosomes using a specific antibody that does not cross-react with other LC3 proteins (Supplementary Figure S2) . When the turnover of autophagosomes in lysosomes was inhibited by treatment with Baf.A1 during autophagy induced by starvation or infection with Ad-p53, the amount of form-II of endogenous LC3Av1 was remarkably increased, as was that of endogenous LC3B (Figure 3a) . Next, we observed the intracellular location of endogenous LC3Av1 in Saos-2 cells. Similar to LC3A gene is involved in autophagy H Bai et al GFP-LC3Av1, endogenous LC3Av1 exhibited a punctate distribution during the induced autophagy ( Figure 3b ). When the starvation-or p53-induced autophagy flux was inhibited by treatment with Baf.A1, LC3Av1-positive puncta, as well as LC3B-positive puncta, were significantly accumulated in the lysosome, being colocalized with LAMP-2, a lysosomal marker (Figures 3b and c) . RT-PCR products were loaded on a 3% agarose gel, and the intensity of each band was measured using Multi Gauge (Fuji film). A Semi-quantitative value was obtained for each LC3 mRNA by normalizing with levels of GAPDH mRNA.
LC3A gene is involved in autophagy H Bai et al
Furthermore, we examined whether LC3Av1 and LC3B can localize in the same autophagosomes during the induced autophagy. When Saos-2 cells stably expressing GFP-LC3Av1 or -LC3B were starved or infected with Ad-p53, endogenous LC3B or LC3Av1 were mostly found in the GFP-LC3Av1 or -LC3B-positive puncta, respectively (Figure 4a ). The frequencies of cells with >10 colocalized dots for 'GFP-LC3A and LC3B' or 'GFP-LC3B and LC3Av1' were 28% and 27%, respectively, in starvation-induced autophagy, and 53% and 48%, respectively, in p53 activation-induced autophagy. Additionally, in Saos-2 cells expressing endogenous LC3Av1 and LC3B, these proteins were also frequently colocalized in the same puncta under the /well) and the next day, either treated with Earle's Balanced Salt Solution (EBSS) alone, EBSS plus Baf.A1 (100 nM), or Baf.A1 alone for the periods indicated, or infected with Ad-LacZ or -p53 at the indicated multiplicity of infection (MOI) for 2 days and before being treated with Baf.A1 (100 nM) for the last 2 h. Whole cell lysate was prepared in 1% Triton-X buffer, subjected to SDS-PAGE, and immunoblotted with rabbit anti-LC3Av1 antibody, rabbit anti-LC3B antibody or mouse-p53 antibody. Arrows indicate the bands for form-II of endogenous LC3Av1 and LC3B. (b) Intracellular distribution of endogenous LC3Av1 or LC3B in Saos-2 cells during autophagy. Saos-2 cells were plated on coverslips in 24-well plates (1 Â 10 5 /well) and the next day, treated as indicated in (a). The cells were fixed in 10% trichloroacetic acid for 15 min on ice, immuno-reacted with rabbit anti-LC3Av1 antibody or rabbit anti-LC3B antibody and mouse anti-LAMP-2 antibody, and visualized using Alexa Fluor594 anti-rabbit or Alexa Fluor488 anti-mouse IgG antibody. The images were obtained by confocal microscopy. (c) Quantitative colocalization analysis between LC3Av1 or LC3B and LAMP-2. Colocalization analysis of LC3Av1 or LC3B with LAMP-2 was performed using the JACoP plugin in ImageJ (NIH Image) as described in the Materials and methods. *Po0.05.
LC3A gene is involved in autophagy H Bai et al autophagy induced by starvation or Ad-p53 infection; 13% in no treatment, 62% in starvation, 11% in Ad-LacZ infection and 57% in Ad-p53 infection, respectively (Figure 4b ). These results suggest that LC3Av1 was colocalized with LC3B in the same autophagosomes during the induced autophagy. Thus our findings indicate that not only LC3B, but also LC3Av1, is closely associated with the autophagy.
Epigenetic inactivation of LC3Av1 in human cancers
There are evidences that the impaired autophagy predisposes individuals to the development of tumors (Rubinsztein, 2006; Mathew et al., 2007; Fleming et al., 2011) , suggesting that genetic or epigenetic alterations in autophagy-related genes may occur in human cancers. Therefore, we examined the expression, at the transcriptional level, of LC3Av1 and LC3B in human cancer cell lines. As shown in Table 1 and Supplementary Figure  S3 , we found that LC3Av1 was completely silenced in 111 of 244 cell lines (45.5%) from various tumors. In contrast, LC3B was ubiquitously expressed in all cell lines examined (Supplementary Figure S3) . The protein level of LC3Av1 was decreased as correlation with the transcriptional level in ESCC cell lines (Figure 5a ). Aberrant methylation of the cytosine of CG sites within CpG island, a CG-rich region, around transcriptional LC3A gene is involved in autophagy H Bai et al start sites is a major factor in the inactivation of tumor suppressor genes in cancer. As there is a CpG island around the transcriptional start site of LC3Av1, we examined the methylation status of CG sites within an arbitrary region including the transcriptional start site by COBRA (combined bisulfite restriction analysis) using HhaI, a methylation-sensitive restriction enzyme (Figure 5b ). In association with the expression pattern of LC3Av1, the digested bands (methylation) were detected in only LC3Av1-silenced cell lines, not in LC3Av1-expressing cell lines (Figure 5c ). Also, bisulfite sequencing revealed that most CG sites within the region examined were frequently methylated in KYSE170 cells (an LC3Av1-silenced cell line), but not in KYSE350 (an LC3Av1-expressing cell line) (Supplementary Figure  S4) . Furthermore, we found that the silenced expression of LC3Av1 was restored by treatment with 5-aza-dC, a demethylation reagent, in the LC3Av1-silenced cell lines (Figure 5d ). These findings suggest that LC3Av1 was epigenetically inactivated by aberrant DNA methylation in ESCC cell lines. A correlation between the silencing of LC3Av1 and DNA methylation was also observed in neuroblastoma and oral squamous cell carcinoma cell lines (data not shown). Furthermore, we examined the expression and methylation status of LC3Av1 in primary ESCCs. A quantitative RT-PCR analysis of paired samples (primary tumors and corresponding non-cancerous tissue) revealed a >50% reduction of LC3Av1 expression in primary tumor tissue compared with the corresponding non-cancerous tissue in 19 of 38 cases (Figure 5e ). Methylation was detected in 6 of the 38 cases by COBRA (Figure 5f ). In three cases (49, 51 and 31), bisulfite sequencing confirmed the frequency of methylation to be increased in primary tumor tissue, compared with non-cancerous tissue (Supplementary Figure S4) . The expression level was significantly decreased in the 6 methylated cases as compared with the 32 unmethylated cases (P ¼ 0.000005) (Figure 5g ). These results indicate that LC3Av1 was frequently inactivated at the transcriptional level in various human cancer cell lines and in primary ESCCs, and the inactivation was due to aberrant DNA methylation.
Effect of LC3Av1 expression for tumor growth
To investigate the significance of LC3Av1 inactivation for tumorigenesis, we first generated the clones stably expressing LC3Av1 from KYSE170 (an LC3Av1-silenced cell line) and confirmed a robust expression of LC3Av1 protein in stably LC3Av1-expressed clones, compared with that in vector clones (as the control), by western blotting and immunofluorecsence analyses (Figures 6a and b) . Significant difference of growth rate between vector clones and stably LC3Av1-expressed clones could not be detected in vitro growth assay (Figure 6c ). In contrast, for in vivo growth assay by subcutaneous transplantation with these clones into the flank of nude mice, we showed the significant decrease in both tumor volume and weight of the stably LC3Av1-expressed clone, compared with that in the vector clone (P ¼ 0.0204 for tumor volume at 17 days, P ¼ 0.0311 for tumor weight) (Figure 6d ). Furthermore, immunohistochemical analysis showed LC3Av1 protein to be continuously expressed in tumors from the LC3Av1-expressed clone, although LC3B protein was similarly expressed in both tumors (Figure 6e ). Taken together, these results suggest that LC3Av1 may inhibit the tumor growth in an environment marked by no anchorage and limited nutrients, and the epigenetic inactivation of this gene may contribute to tumorigenesis of ESCC.
Discussion
The human LC3 gene family has five members, LC3A (variant-1: v1 and variant-2: v2), LC3B, LC3B2 and LC3C, among which LC3B is crucial for autophagy (Kabeya et al., 2000 (Kabeya et al., , 2004 He et al., 2003) . One key finding of the present study is that LC3Av1 is also associated with autophagy, frequently localizing in autophagosomes and generating form-II, during starvation-and p53-induced autophagy in Saos-2 cells. The C-terminal residue Gly120 is essential for LC3B's modification by PE and localization in autophagosomes (Tanida et al., 2004) . Other LC3 proteins also have a Gly residue in the C-terminus. Nonetheless, LC3Av2, LC3B2 and LC3C were mostly absent from autophagosomes in Saos-2 cells. LC3Av1 and LC3Av2 differ in their transcriptional start sites resulting in a different amino acid in the N-terminal region. The N-terminal region of LC3B shows high identity to that of LC3Av1. LC3B and LC3B2 differ in one amino acid (Tyr for LC3B and Cys for LC3B2 at position 113). LC3Av1 and LC3Av2 also have Tyr113. Taken together, these findings suggest that not only the C-terminal Gly120 residue, but also the N-terminus and Tyr113 residue contribute to the localization in autophagosomes and the modification by PE of the LC3 protein.
In this study, we found that GFP-LC3C was constantly shown as smaller punctate pattern even under normal conditions, and the number of GFP-LC3C-positive small puncta was not clearly changed either after induction of the autophagy or pharmacological inhibition of the basal autophagy. Based on the difference of amino-acid sequences between LC3C and (Figure 1d ), our findings support the notion that LC3C may exert the physiological function except for conventional autophagy, such as the regulation of microtubule dynamics. To validate this hypothesis, it will be required for further experiments using LC3C-specific antibody. Recent studies have suggested that impaired autophagy may predispose an individual to tumorigenesis LC3A gene is involved in autophagy H Bai et al (Rubinsztein, 2006; Mathew et al., 2007; Fleming et al., 2011) . This is supported by an increased incidence of tumors in mouse models with a haploinsufficiency or deficiency of autophagy-related genes such as Becn1, Atg5, Atg7, Atg4c and Zbtb24 (Qu et al., 2003; Yousefi et al., 2006; Marin˜o et al., 2007; Takahashi et al., 2007; Inami et al., 2011; Komatsu, 2011; Takamura et al., 2011) . Thus, genetic aberrations affecting autophagy may be a factor in human cancers. Although a monoallelic deletion of Becn1 has been reported in breast tumors (Liang et al., 1999; Qu et al., 2003; Yue et al., 2003) , no genetic or epigenetic modifications of other autophagy-related genes have been identified in human cancers. In this study, we found that LC3Av1 was frequently inactivated at the transcriptional level in various human cancer cell lines and at least some primary ESCCs, and its inactivation was due to epigenetic changes through aberrant DNA methylation. However, a recent immunohistochemical analysis in tumor tissues revealed a 'stone-like' staining pattern of LC3A to be associated with a poor prognosis among patients with epithelial tumors, including colorectal adenocarcinoma, non-small cell lung carcinoma, and breast tumors (Giatromanolaki et al., 2010; Karpathiou et al., 2010; Sivridis et al., 2010a Sivridis et al., , 2010b Sivridis et al., , 2011 . However, the specificity of the LC3A antibody used was not examined, though LC3Av1 and LC3B are highly homologous in amino-acid sequence. Further LC3A gene is involved in autophagy H Bai et al immunohistochemical analysis using a LC3Av1-specific antibody, with absolutely no cross-reactions with other LC3 proteins, is required to examine the correlation between LC3A expression and clinicopathological findings including prognosis in tumors.
LC3b knockout mice develop normally, and have less severe phenotypes than knockout mice lacking other autophagy-related genes such as ATG5 and ATG7 (Kuma et al., 2004; Komatsu et al., 2005; Cann et al., 2008) . Such observations support the presence of a compensatory mechanism involving other proteins, such as g-aminobutyric-acid-type-A-receptor-associated protein and Golgiassociated ATPase enhancer of 16 kDa in the autophagosome (Kabeya et al., 2004; Cann et al., 2008) . As LC3Av1 was modified by PE and detected in LC3B-positive autophagosome during starvation-and p53-induced autophagy, its loss may be functionally compensated for by LC3B, g-aminobutyric-acid-type-A-receptor-associated protein and Golgi-associated ATPase enhancer of 16 kDa under conditions that induce autophagy. However, we found that the aberrant DNA methylation involved in LC3Av1, but not in LC3B, in human cancers and reexpression of LC3Av1 protein in an ESCC cell line resulted in the inhibition of in vivo tumor growth, not in vitro growth. These findings strongly suggest that LC3Av1 may have a particular kind of tumor-suppressive role, which is not compensated by at least LC3B, during tumor formation in an environment marked by no anchorage and limited nutrients.
On the other hand, the LC3b protein regulates microtubule stability (Faller et al., 2009 ) and microtubule instability is closely associated with tumorigenesis through a defect in chromosomal segregation. At present, it is not clear whether LC3Av1 is associated with the regulation of microtubules. The contribution to tumorigenesis of the impairment of autophagy and/or microtubules, which may occur with the inactivation of LC3Av1 needs to be clarified. Further examination including experiments in LC3Av1 knockout mice will be needed to understand the significance of the inactivation of LC3Av1 to cancers.
Materials and methods
Cell culture, isolation of stable clones and induction of autophagy Saos-2 cells were grown in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, penicillin and streptomycin at 37 1C with 5% CO 2 . The cells were transfected with plasmid DNA using Lipofectoamine 2000 (Invitrogen, Carlsbad, CA, USA). Stable clones expressing each GFP-LC3 in Saos-2 cells were selected in 600 mg/ml of geneticin (G418, Sigma), and colonies numbering >10 were pooled to avoid the effects of clonal variation. Stable clones expressing each expression element, pcDNA-empty vector or -LC3Av1 vector, in KYSE170 cells were selected in 1000 mg/ml of geneticin (G418, Sigma, St Louis, MO, USA), and the clones were independently picked up. For the induction of autophagy, the cells were treated with Earle's Balanced Salt Solution (Invitrogen) for 2 h or infected with Ad-p53 at a multiplicity of infection of 20 for 2 days. The Ad-p53 was prepared following the manufacturer's recommendations as previously described (Inoue et al., 2009 ). Viral titers were measured in pfu/ ml by a limiting-dilution method using the HEK293 cells. Cells were infected with each multiplicity of infection (PFU/cell).
Primary samples
Samples of primary tumors and corresponding non-cancerous esophageal mucosae obtained during surgery from 38 ESCC patients undergoing tumor resections at the Tokyo Medical and Dental University Hospital (Tokyo, Japan) were used. The tissues had been immediately frozen in liquid nitrogen and stored at À80 1C until required.
Reagents and antibodies
Baf.A1 was purchased from Sigma-Aldrich Laboratories (St Louis, MO, USA). Rabbit and mouse anti-GFP antibody (MBL, Woburn, MA, USA), rabbit anti-LC3A antibody (Sigma), rabbit anti-LC3B antibody (Sigma), goat anti-LC3B antibody (Santa Cruz, Santa Cruz, CA, USA), mouse anti-LAMP-2 antibody (Santa Cruz) and mouse anti-b-actin (Sigma) were used for the western blotting analysis and/or immunofluorecence analysis.
Information on human LC3 genes
Information on the human LC3 gene sequence was obtained using the Gene ID and Accession No. from the NCBI database (http://www.ncbi.nlm.nih.gov/).
Construction of plasmids
The expression vector encoding human LC3Av1, LC3Av2, LC3B or LC3C fused with GFP was constructed by inserting the full-length cDNA fragment prepared by RT-PCR into pEGFP-C1 vector (Clontech, Mountain View, CA, USA). The insertion was confirmed by sequencing. The GFP-rLC3b expression vector was kindly provided by Dr T Yoshimori. The expression vector for GFP-LC3B2 was generated from GFP-LC3B by Gene-taillar, PCR-based site-directed mutagenesis (Invitrogen). To generate LC3Av1-stably expressing clones, the expression vector encoding human LC3Av1 was constructed by inserting the full-length cDNA fragment prepared by RT-PCR into pcDNA 3.1 vector (Invitrogen).
RNA isolation and RT-PCR
Total RNA was isolated using TRIzol reagent (Invitrogen) according to standard procedures. Single-stranded cDNA generated from the total RNA was amplified with primer set specific for each gene. For standard RT-PCR, the PCR products were loaded on a 3% agarose gel and images were captured using a LAS-3000 (FUJI film, Tokyo, Japn). The expression was normalized to GAPDH levels.
Quantitative real-time RT-PCR
For quantitative real-time RT-PCR, probes for LC3Av1 and LC3B were purchased from KAPA PROBE FAST system (KAPA BIOSYSTEMS, Woburn, MA, USA). The RT-PCR was performed using an ABI PRISM 7500 sequence detection System (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer's instructions. Gene expression values are given as ratios (differences between the Ct values) between the genes of interest and an internal reference (GAPDH) that provides a normalization factor for the amount of RNA isolated from a specimen, and subsequently normalized with the value in the control cells (relative expression level).
Immunofluorecence analysis
The cells were fixed in 4% formaldehyde or 10% trichloroacetic acid, permeabilized with 0.2%. Triton X-100, and Western blotting Whole-cell lysate was prepared in a 1% Triton-X solution with the complete mini, EDTA-free protease inhibitor mixture (Roche Applied Science, Indianapolis, IN, USA) or in SDS sample buffer. The lysate was incubated on a rotating apparatus at 4 1C for 30 min and cleared by centrifugation at 12 000 rpm for 30 min at 4 1C. The proteins in the supernatant were resolved by SDS-PAGE and transferred to a PVDF membrane. After blocking with TBS containing 0.05% Tween 20 and 5% non-fat dry milk for 1 h, the membrane was reacted with an antibody overnight. The primary antibodies and dilutions used were: rabbit anti-LC3A (1/5000), rabbit anti-LC3B (1/5000), goat anti-LC3B (1/2000), mouse anti-b-actin (1/5000) and rabbit anti-GFP antibody (1/1000). The membrane was washed and exposed to horseradish peroxidaseconjugated goat anti-mouse or rabbit IgG or donkey anti-goat antibodies (both at 1/2000) for 1 h. The bound antibodies were visualized with HRP staining solution or with an ECL western detection kit according to the manufacturer's instructions (Cell Signaling Technology, Beverly, MA, USA).
DNA methylation analysis
Genomic DNA was treated with sodium bisulfite using an EZ DNA methylation kit (Zymo Research, Irvine, CA, USA) and subjected to PCR with primer sets designed to amplify regions of interest. For COBRA, the PCR products were digested with HhaI and separated on a 3% agarose gel. For bisulfite sequencing, the PCR products were subcloned and then sequenced.
In vivo tumor growth assay The in vivo tumor-suppressive ability of LC3Av1 was investigated by conducting tumor xenograft experiments. 6-week-old female Balb/C athymic nude mice (nu/nu) were injected subcutaneously into the flanks in nude mice (4 Â 10 6 cells/injection). All procedures involving animals were approved by and conformed to the guidelines of our Institutional Animal Care and Use Committee. Tumor size was measured by a slide caliper and tumor volume was determined by the formula; 4/3 Â p Â (1/2 Â smaller diameter) 2 Â 1/2(larger diameter). At 17 days postinjection, the tumor were rapidly taken out and fixed in 10% neutral buffered formalin, embedded in paraffin. Sections of 5 mM were cut and stained with haematoxylin and eosin according to standard protocols. Sections were further under immunohistochemical staining using antibodies against LC3Av1 and LC3B.
Immunohistochemistry
Sections from paraffin-embedded tumor samples were deparaffinized by xylene, and rehydrated in ethanol. After retrieval of antigens by boiling in 10 mM citrate buffer (pH 6.0), the sections were treated with 0.3% hydrogen peroxide in methanol to inactivate the endogenous peroxidase. Then, the sections were incubated with an antibody against LC3Av1 (1:2000) or LC3B (1:2000) for 1 h at room temperature. The bound antibody was visualized using diaminobenzidine as a chromogen (VECTASTAIN _ Elute ABC kit, Vector Laboratories, Burlingame, CA, USA), and the sections were lightly counterstained with hematoxylin.
Statistical analysis
The results of the quantitative expression analysis in primary tumor samples were presented as the mean and s.d. Differences were associated with a two-sided test (Student's t-test).
